Community-acquired pneumonia
First line
Moderate-to-severe community-acquired pneumonia. /ATS 2019 and Spanish SEPAR 2024 position ceftriaxone 1-2 g once daily as the empiric backbone in hospitalized patients combined with a macrolide ( 500 mg or ) or a respiratory fluoroquinolone (). Treatment duration 5-7 days with typical response. ICU patients receive 2 g/day.